Amivantamab Plus Chemotherapy in Japanese Patients With EGFR Exon 20 Insertions NSCLC. Kitazono S, Ono A, Kawamura T, Hataji O, et al. Cancer Sci 2025;116:3139-3148.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kitazono S, Ono A, Kawamura T, Hataji O, et al. Amivantamab Plus Chemotherapy in Japanese Patients With EGFR Exon 20 Insertions NSCLC. Cancer Sci 2025;116:3139-3148.
PMID: 40922529